Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anne Reiner

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Epidemiology (Cambridge, Mass.)|March 20, 2010
Evaluating cancer epidemiologic risk factors using multiple primary malignanciesEkatherina Kuligina, Anne Reiner, Evgeny N Imyanitov, et al.
Neurosurgery|June 19, 2012
Subdural hematoma in patients with cancerJordan Reichman, Samuel Singer, Babak Navi, et al.
Journal of the American Chemical Society|August 30, 2016
Twisted Hemithioindigo Photoswitches: Solvent Polarity Determines the Type of Light-Induced RotationsSandra Wiedbrauk, Benjamin Maerz, Elena Samoylova, et al.
Neurology|April 5, 2013
Rare cell capture technology for the diagnosis of leptomeningeal metastasis in solid tumorsLakshmi Nayak, Martin Fleisher, Rita Gonzalez-Espinoza, et al.
International Journal of Radiation Oncology, Biology, Physics|October 12, 2010
[¹⁸F]FDG-positron emission tomography coregistration with computed tomography scans for radiation treatment planning of lymphoma and hematologic malignanciesStephanie A Terezakis, Margie A Hunt, Alexander Kowalski, et al.
Journal of Neuro-Oncology|April 19, 2022
Coping with glioblastoma: prognostic communication and prognostic understanding among patients with recurrent glioblastoma, caregivers, and oncologistsLeah E Walsh, Laura C Polacek, Katherine Panageas, et al.
Neuro-Oncology|June 25, 2017
Prognostic awareness, prognostic communication, and cognitive function in patients with malignant gliomaEli L Diamond, Holly G Prigerson, Denise C Correa, et al.
Neuro-Oncology Advances|January 7, 2022
Quantitative cerebrospinal fluid circulating tumor cells are a potential biomarker of response for proton craniospinal irradiation for leptomeningeal metastasisN Ari Wijetunga, Adrienne Boire, Robert J Young, et al.
Neuro-Oncology|January 18, 2020
Neurologic and oncologic features of Erdheim-Chester disease: a 30-patient seriesAnkush Bhatia, Vaios Hatzoglou, Gary Ulaner, et al.
Pigment Cell & Melanoma Research|January 11, 2014
MITF E318K's effect on melanoma risk independent of, but modified by, other risk factorsMarianne Berwick, Jamie MacArthur, Irene Orlow, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Epidemiology (Cambridge, Mass.)|March 20, 2010
Evaluating cancer epidemiologic risk factors using multiple primary malignanciesEkatherina Kuligina, Anne Reiner, Evgeny N Imyanitov, et al.
Neurosurgery|June 19, 2012
Subdural hematoma in patients with cancerJordan Reichman, Samuel Singer, Babak Navi, et al.
Journal of the American Chemical Society|August 30, 2016
Twisted Hemithioindigo Photoswitches: Solvent Polarity Determines the Type of Light-Induced RotationsSandra Wiedbrauk, Benjamin Maerz, Elena Samoylova, et al.
Neurology|April 5, 2013
Rare cell capture technology for the diagnosis of leptomeningeal metastasis in solid tumorsLakshmi Nayak, Martin Fleisher, Rita Gonzalez-Espinoza, et al.
International Journal of Radiation Oncology, Biology, Physics|October 12, 2010
[¹⁸F]FDG-positron emission tomography coregistration with computed tomography scans for radiation treatment planning of lymphoma and hematologic malignanciesStephanie A Terezakis, Margie A Hunt, Alexander Kowalski, et al.
Journal of Neuro-Oncology|April 19, 2022
Coping with glioblastoma: prognostic communication and prognostic understanding among patients with recurrent glioblastoma, caregivers, and oncologistsLeah E Walsh, Laura C Polacek, Katherine Panageas, et al.
Neuro-Oncology|June 25, 2017
Prognostic awareness, prognostic communication, and cognitive function in patients with malignant gliomaEli L Diamond, Holly G Prigerson, Denise C Correa, et al.
Neuro-Oncology Advances|January 7, 2022
Quantitative cerebrospinal fluid circulating tumor cells are a potential biomarker of response for proton craniospinal irradiation for leptomeningeal metastasisN Ari Wijetunga, Adrienne Boire, Robert J Young, et al.
Neuro-Oncology|January 18, 2020
Neurologic and oncologic features of Erdheim-Chester disease: a 30-patient seriesAnkush Bhatia, Vaios Hatzoglou, Gary Ulaner, et al.
Pigment Cell & Melanoma Research|January 11, 2014
MITF E318K's effect on melanoma risk independent of, but modified by, other risk factorsMarianne Berwick, Jamie MacArthur, Irene Orlow, et al.
Pageof 1